Cabo Verde

Cabo Verde

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
6.52 (5.05 - 7.62) 2019 Modelled IHME
6.62 (5.24 - 7.68) 2018 Modelled IHME
6.75 (5.37 - 7.88) 2017 Modelled IHME
6.96 (5.76 - 8.07) 2016 Modelled IHME
7.19 (6 - 8.39) 2015 Modelled IHME
7.39 (6.21 - 8.52) 2014 Modelled IHME
7.59 (6.37 - 8.67) 2013 Modelled IHME
7.78 (6.50 - 8.86) 2012 Modelled IHME
7.97 (6.61 - 9.12) 2011 Modelled IHME
8.13 (6.70 - 9.39) 2010 Modelled IHME
8.28 (6.81 - 9.47) 2009 Modelled IHME
8.41 (6.86 - 9.63) 2008 Modelled IHME
8.54 (6.90 - 9.82) 2007 Modelled IHME
8.68 (6.94 - 10.02) 2006 Modelled IHME
8.82 (7.01 - 10.36) 2005 Modelled IHME
9 (7.20 - 10.54) 2004 Modelled IHME
9.2 (7.40 - 10.74) 2003 Modelled IHME
9.41 (7.61 - 10.99) 2002 Modelled IHME
9.61 (7.75 - 11.32) 2001 Modelled IHME
9.78 (7.87 - 11.64) 2000 Modelled IHME
9.95 (8.13 - 11.75) 1999 Modelled IHME
10.13 (8.41 - 11.98) 1998 Modelled IHME
10.29 (8.62 - 12.07) 1997 Modelled IHME
10.41 (8.69 - 12.20) 1996 Modelled IHME
10.47 (8.72 - 12.31) 1995 Modelled IHME
10.49 (8.73 - 12.33) 1994 Modelled IHME
10.5 (8.74 - 12.36) 1993 Modelled IHME
10.5 (8.71 - 12.41) 1992 Modelled IHME
10.5 (8.61 - 12.43) 1991 Modelled IHME
10.48 (8.50 - 12.56) 1990 Modelled IHME
5.23 (2.76 - 8.47) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.68 (0.51 - 0.87) 2019 Modelled IHME
0.73 (0.56 - 0.92) 2018 Modelled IHME
0.77 (0.58 - 0.99) 2017 Modelled IHME
0.8 (0.61 - 1.02) 2016 Modelled IHME
0.82 (0.62 - 1.05) 2015 Modelled IHME
0.79 (0.60 - 1.02) 2014 Modelled IHME
0.72 (0.54 - 0.92) 2013 Modelled IHME
0.63 (0.48 - 0.80) 2012 Modelled IHME
0.56 (0.42 - 0.71) 2011 Modelled IHME
0.53 (0.39 - 0.68) 2010 Modelled IHME
0.62 (0.47 - 0.79) 2009 Modelled IHME
0.88 (0.67 - 1.11) 2008 Modelled IHME
1.26 (0.97 - 1.59) 2007 Modelled IHME
1.73 (1.34 - 2.18) 2006 Modelled IHME
2.24 (1.73 - 2.86) 2005 Modelled IHME
3.11 (2.40 - 3.97) 2004 Modelled IHME
4.46 (3.41 - 5.68) 2003 Modelled IHME
5.93 (4.50 - 7.57) 2002 Modelled IHME
7.16 (5.39 - 9.28) 2001 Modelled IHME
7.82 (5.83 - 10.24) 2000 Modelled IHME
8.04 (6.05 - 10.55) 1999 Modelled IHME
8.22 (6.21 - 10.87) 1998 Modelled IHME
8.36 (6.28 - 11.07) 1997 Modelled IHME
8.45 (6.35 - 11.13) 1996 Modelled IHME
8.5 (6.31 - 11.24) 1995 Modelled IHME
8.53 (6.38 - 11.15) 1994 Modelled IHME
8.55 (6.43 - 11.07) 1993 Modelled IHME
8.57 (6.43 - 11.09) 1992 Modelled IHME
8.57 (6.40 - 11.10) 1991 Modelled IHME
8.57 (6.40 - 11.12) 1990 Modelled IHME
0.71 (0.35 - 1.42) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
46 (38 - 55) 2019 Modelled IHME
46 (38 - 54) 2018 Modelled IHME
47 (39 - 55) 2017 Modelled IHME
46 (39 - 55) 2016 Modelled IHME
47 (40 - 55) 2015 Modelled IHME
47 (40 - 55) 2014 Modelled IHME
48 (40 - 56) 2013 Modelled IHME
48 (40 - 56) 2012 Modelled IHME
49 (42 - 57) 2011 Modelled IHME
49 (42 - 57) 2010 Modelled IHME
49 (42 - 57) 2009 Modelled IHME
49 (41 - 57) 2008 Modelled IHME
48 (41 - 57) 2007 Modelled IHME
48 (40 - 57) 2006 Modelled IHME
48 (40 - 57) 2005 Modelled IHME
48 (40 - 57) 2004 Modelled IHME
48 (40 - 57) 2003 Modelled IHME
48 (40 - 57) 2002 Modelled IHME
48 (40 - 58) 2001 Modelled IHME
49 (40 - 58) 2000 Modelled IHME
49 (40 - 58) 1999 Modelled IHME
48 (40 - 57) 1998 Modelled IHME
48 (40 - 57) 1997 Modelled IHME
47 (39 - 56) 1996 Modelled IHME
46 (38 - 56) 1995 Modelled IHME
46 (37 - 55) 1994 Modelled IHME
45 (37 - 55) 1993 Modelled IHME
45 (36 - 54) 1992 Modelled IHME
45 (36 - 54) 1991 Modelled IHME
44 (36 - 54) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
96 2017 Survey/reported WHO/UNICEF
96 2016 Survey/reported WHO/UNICEF
93 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
94 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
91 2009 Survey/reported WHO/UNICEF
81 2008 Survey/reported WHO/UNICEF
84 2007 Survey/reported WHO/UNICEF
68 2006 Survey/reported WHO/UNICEF
68 2005 Survey/reported WHO/UNICEF
75 2004 Survey/reported WHO/UNICEF
76 2003 Survey/reported WHO/UNICEF
77 2002 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
97 2017 Survey/reported WHO/UNICEF
96 2016 Survey/reported WHO/UNICEF
94 2015 Survey/reported WHO/UNICEF
96 2014 Survey/reported WHO/UNICEF
93 2013 Survey/reported WHO/UNICEF
94 2012 Survey/reported WHO/UNICEF
90 2011 Survey/reported WHO/UNICEF
98 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
98 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
93 2005 Survey/reported WHO/UNICEF
91 2004 Survey/reported WHO/UNICEF
66 2003 Survey/reported WHO/UNICEF
40 2002 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2002
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.53 (2.04 - 3.15) 2019 Modelled IHME
2.52 (2.05 - 3.12) 2018 Modelled IHME
2.5 (2.04 - 3.12) 2017 Modelled IHME
2.47 (2 - 3.07) 2016 Modelled IHME
2.45 (1.96 - 3.03) 2015 Modelled IHME
2.45 (1.97 - 3.03) 2014 Modelled IHME
2.45 (1.97 - 3.03) 2013 Modelled IHME
2.46 (1.96 - 3.04) 2012 Modelled IHME
2.47 (1.96 - 3.05) 2011 Modelled IHME
2.47 (1.96 - 3.07) 2010 Modelled IHME
2.47 (1.97 - 3.07) 2009 Modelled IHME
2.48 (1.97 - 3.08) 2008 Modelled IHME
2.48 (1.97 - 3.09) 2007 Modelled IHME
2.48 (1.98 - 3.09) 2006 Modelled IHME
2.49 (1.99 - 3.09) 2005 Modelled IHME
2.49 (2 - 3.10) 2004 Modelled IHME
2.5 (2 - 3.10) 2003 Modelled IHME
2.5 (2.01 - 3.11) 2002 Modelled IHME
2.51 (2.02 - 3.11) 2001 Modelled IHME
2.52 (2.04 - 3.13) 2000 Modelled IHME
2.52 (2.04 - 3.12) 1999 Modelled IHME
2.53 (2.04 - 3.14) 1998 Modelled IHME
2.54 (2.04 - 3.17) 1997 Modelled IHME
2.56 (2.04 - 3.20) 1996 Modelled IHME
2.56 (2.05 - 3.22) 1995 Modelled IHME
2.57 (2.07 - 3.22) 1994 Modelled IHME
2.58 (2.07 - 3.24) 1993 Modelled IHME
2.59 (2.08 - 3.25) 1992 Modelled IHME
2.6 (2.09 - 3.26) 1991 Modelled IHME
2.61 (2.10 - 3.27) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
19 (14 - 26) 2019 Modelled IHME
20 (14 - 26) 2018 Modelled IHME
20 (14 - 26) 2017 Modelled IHME
20 (15 - 27) 2016 Modelled IHME
20 (15 - 26) 2015 Modelled IHME
20 (14 - 26) 2014 Modelled IHME
20 (14 - 26) 2013 Modelled IHME
20 (15 - 26) 2012 Modelled IHME
19 (14 - 25) 2011 Modelled IHME
19 (14 - 25) 2010 Modelled IHME
20 (14 - 26) 2009 Modelled IHME
20 (15 - 26) 2008 Modelled IHME
20 (15 - 26) 2007 Modelled IHME
20 (15 - 27) 2006 Modelled IHME
20 (14 - 26) 2005 Modelled IHME
20 (14 - 26) 2004 Modelled IHME
20 (14 - 27) 2003 Modelled IHME
20 (15 - 27) 2002 Modelled IHME
20 (14 - 27) 2001 Modelled IHME
20 (14 - 27) 2000 Modelled IHME
21 (15 - 27) 1999 Modelled IHME
21 (15 - 28) 1998 Modelled IHME
21 (15 - 28) 1997 Modelled IHME
22 (15 - 29) 1996 Modelled IHME
22 (15 - 30) 1995 Modelled IHME
23 (16 - 30) 1994 Modelled IHME
23 (16 - 31) 1993 Modelled IHME
23 (16 - 31) 1992 Modelled IHME
23 (16 - 31) 1991 Modelled IHME
23 (16 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2002
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
6.52 (%)
2019
(5.05 - 7.62(%))
IHME
HCV (RNA/cAg+)
2.53 (%)
2019
(2.04 - 3.15(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
73
2019
(58 - 92)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
18
2019
(13 - 23)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.68 (%)
2019, latest modelled
(0.51 - 0.87(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
97 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines